BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register

TRAX

First Tracks Biotherapeutics Inc NASDAQ Listed Apr 20, 2026
$40.46
-4.82% vs $42.51
Mkt Cap $1.4B
52w Low $14.72 73.1% of range 52w High $49.91
50d MA $37.69 200d MA $27.76
P/E (TTM)
EV/EBITDA
P/B
Debt/Equity
ROE
P/FCF
RSI (14) 43.10
ATR (14) $2.77
Beta 0.00
50d MA $37.69
200d MA $27.76
Avg Volume 697.7K
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
SIC Code
2834
CIK (SEC)
Phone
212-373-3000
10770 WATERIDGE CIRCLE · San Diego, CA 92121 · US
Data updated apr 27, 2026 5:29am · Source: financialmodelingprep.com